Stifel Financial Corp Novartis Ag Transaction History

Stifel Financial Corp

  • $85.8 Billion
  • Q1 2024

A detailed history of Stifel Financial Corp transactions in Novartis Ag stock. As of the latest transaction made, Stifel Financial Corp holds 259,370 shares of NVS stock, worth $27.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
259,370
Previous 250,310 3.62%
Holding current value
$27.6 Million
Previous $25.3 Million 0.73%
% of portfolio
0.03%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$95.27 - $108.47 $863,146 - $982,738
9,060 Added 3.62%
259,370 $25.1 Million
Q4 2023

Feb 12, 2024
SELL
$92.27 - $101.54 $126,502 - $139,211
-1,371 Reduced 0.54%
250,310 $25.3 Million
Q3 2023

Nov 13, 2023
BUY
$94.73 - $105.13 $517,983 - $574,850
5,468 Added 2.22%
251,681 $25.6 Million
Q2 2023

Aug 14, 2023
SELL
$92.52 - $104.91 $1.88 Million - $2.13 Million
-20,346 Reduced 7.63%
246,213 $24.8 Million
Q1 2023

May 12, 2023
BUY
$80.03 - $92.81 $554,367 - $642,894
6,927 Added 2.67%
266,559 $24.5 Million
Q4 2022

Feb 13, 2023
SELL
$75.55 - $92.52 $1.9 Million - $2.33 Million
-25,139 Reduced 8.83%
259,632 $23.6 Million
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $5.76 Million - $6.73 Million
-77,145 Reduced 21.32%
284,771 $21.6 Million
Q2 2022

Aug 15, 2022
SELL
$80.52 - $93.75 $994,341 - $1.16 Million
-12,349 Reduced 3.3%
361,916 $30.6 Million
Q1 2022

May 13, 2022
BUY
$80.11 - $90.62 $2.29 Million - $2.59 Million
28,574 Added 8.27%
374,265 $32.8 Million
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $1.39 Million - $1.53 Million
-17,392 Reduced 4.79%
345,691 $30.2 Million
Q3 2021

Nov 15, 2021
BUY
$81.78 - $95.14 $2.92 Million - $3.4 Million
35,711 Added 10.91%
363,083 $29.7 Million
Q2 2021

Aug 13, 2021
SELL
$85.24 - $94.15 $574,176 - $634,194
-6,736 Reduced 2.02%
327,372 $29.9 Million
Q1 2021

May 14, 2021
SELL
$83.5 - $98.47 $5.37 Million - $6.33 Million
-64,271 Reduced 16.13%
334,108 $28.6 Million
Q4 2020

Feb 12, 2021
BUY
$78.07 - $94.43 $26,387 - $31,917
338 Added 0.08%
398,379 $37.6 Million
Q3 2020

Nov 16, 2020
BUY
$82.14 - $91.0 $842,099 - $932,932
10,252 Added 2.64%
398,041 $34.6 Million
Q2 2020

Aug 14, 2020
SELL
$80.93 - $91.1 $2.39 Million - $2.69 Million
-29,560 Reduced 7.08%
387,789 $33.9 Million
Q1 2020

May 14, 2020
SELL
$70.67 - $99.01 $3.79 Million - $5.31 Million
-53,601 Reduced 11.38%
417,349 $34.3 Million
Q4 2019

Feb 13, 2020
BUY
$84.35 - $95.37 $7.33 Million - $8.28 Million
86,866 Added 22.62%
470,950 $44.6 Million
Q3 2019

Nov 19, 2019
SELL
$85.54 - $94.26 $18,818 - $20,737
-220 Reduced 0.06%
384,084 $33.4 Million
Q3 2019

Nov 13, 2019
SELL
$85.54 - $94.26 $5.9 Million - $6.5 Million
-68,988 Reduced 15.22%
384,304 $33.4 Million
Q2 2019

Aug 14, 2019
BUY
$75.4 - $92.8 $6.57 Million - $8.09 Million
87,188 Added 23.82%
453,292 $41.3 Million
Q1 2019

May 14, 2019
SELL
$75.32 - $86.15 $331,332 - $378,973
-4,399 Reduced 1.19%
366,104 $35.2 Million
Q4 2018

Feb 13, 2019
BUY
$73.66 - $82.02 $5.3 Million - $5.9 Million
71,934 Added 24.09%
370,503 $31.8 Million
Q3 2018

Nov 13, 2018
SELL
$66.94 - $77.43 $340,590 - $393,963
-5,088 Reduced 1.68%
298,569 $25.7 Million
Q2 2018

Aug 14, 2018
BUY
$64.91 - $73.36 $1.49 Million - $1.69 Million
23,026 Added 8.21%
303,657 $23 Million
Q1 2018

May 11, 2018
BUY
$70.39 - $84.15 $306,970 - $366,978
4,361 Added 1.58%
280,631 $22.7 Million
Q4 2017

Feb 14, 2018
BUY
$72.33 - $77.64 $435,354 - $467,315
6,019 Added 2.23%
276,270 $23.2 Million
Q3 2017

Nov 13, 2017
BUY
$74.14 - $77.27 $20 Million - $20.9 Million
270,251
270,251 $0

Others Institutions Holding NVS

# of Institutions
1,343
Shares Held
140M
Call Options Held
1.15M
Put Options Held
866K
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $229B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email